Jay Pharma to File IND Applications to FDA for a clinical study of proprietary formulations in Radiodermatitis and a combination Therapy in Glioblastoma

Jay Pharma to File IND Applications to FDA for a clinical study of proprietary formulations in Radiodermatitis and a combination Therapy in Glioblastoma

ATLANTA, July 29, 2020 /PRNewswire/ — AMERI Holdings, Inc. (NASDAQ: AMRH) (“Ameri”), announced that its proposed amalgamation partner Jay Pharma Inc. (“Jay Pharma” or “the Company”) has announced th…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *